PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28246302-5	2017	Ectopic overexpression of Tbeta4 in hepatocellular carcinoma cells could significantly enhance sphere-forming capacities and infiltrating phenotypes in vitro, and promote growth of tumors refractory to the VEGFR multikinase inhibitor sorafenib in vivo Clinically, sorafenib failed to improve the progression-free survival in patients with Tbeta4-high hepatocellular carcinoma, indicating that Tbeta4 expression could be available as a surrogate marker of susceptibility to this drug.	Sorafenib	234-243	thymosin beta 4 X-linked	Homo sapiens	26-32	
28246302-5	2017	Ectopic overexpression of Tbeta4 in hepatocellular carcinoma cells could significantly enhance sphere-forming capacities and infiltrating phenotypes in vitro, and promote growth of tumors refractory to the VEGFR multikinase inhibitor sorafenib in vivo Clinically, sorafenib failed to improve the progression-free survival in patients with Tbeta4-high hepatocellular carcinoma, indicating that Tbeta4 expression could be available as a surrogate marker of susceptibility to this drug.	Sorafenib	264-273	thymosin beta 4 X-linked	Homo sapiens	26-32